Gilder Gagnon Howe & Co’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-12,335
Closed -$82K 284
2013
Q3
$82K Buy
+12,335
New +$290K ﹤0.01% 240

Other funds holding RNA

Gilder Gagnon Howe & Co's RNA Position: Q4 2013 in Review

Gilder Gagnon Howe & Co sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2013, closing a stake of 12,335 shares — an estimated $82K sold.

Gilder Gagnon Howe & Co first reported a position in RNA in Q3 2013 and held it in 1 quarter. The position peaked at $82K in Q3 2013. 22 funds tracked by Wall St. Rank hold RNA as of Q4 2013.

  • Gilder Gagnon Howe & Co reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2013 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 12,335 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2013, an estimated $82K.
  • Gilder Gagnon Howe & Co first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $82K in Q3 2013.
  • 22 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2013.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2013, filed 14 Feb 2014.